NCT04208815 is a NA clinical trial of Milk Polar Lipids in Serum Cholesterol, sponsored by University of Connecticut.

Who is sponsoring NCT04208815?

NCT04208815 is sponsored by University of Connecticut.

What drugs are being tested in NCT04208815?

Interventions in NCT04208815: Milk Polar Lipids, Milk Fat.

What condition does NCT04208815 study?

NCT04208815 studies Serum Cholesterol, Gut Microbiome.

Is NCT04208815 still recruiting?

NCT04208815 is currently completed. Last updated 13 January 2022.

Last reviewed 2022-01-13 · How we verify

NCT04208815

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Dietary Milk Polar Lipids on Serum Cholesterol and Gut Microbiota in Healthy Adults

Completed NA Last updated 13 January 2022

What this trial tests

NA trial testing Milk Polar Lipids in Serum Cholesterol in 35 participants. Completed in 31 October 2021.

Timeline

1 March 2020

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	University of Connecticut
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	35
Start date	1 March 2020
Primary completion	31 October 2021
Estimated completion	31 October 2021
Sites	1 location across United States

Drugs / interventions tested

Milk Polar Lipids
Milk Fat

Conditions studied

Serum Cholesterol — all drugs for Serum Cholesterol →
Gut Microbiome — all drugs for Gut Microbiome →

Sponsor

University of Connecticut

Who can join

Adults 18 to 50, any sex, with Serum Cholesterol or Gut Microbiome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine whether the daily consumption of 5 g of milk polar lipids influences serum lipids and gut microbiota composition in healthy adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Connecticut trials

Trials by the same sponsor.

NCT06794840 — JomCare Study - A Harm Reduction Study · NA · not yet recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT06381921 — Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain · NA · recruiting
NCT06393725 — Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions · NA · recruiting
NCT04989309 — Left and Right Hemisphere Contributions to Speech Perception · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04208815 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Connecticut
Last refreshed: 13 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04208815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing